Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Cancer Type/Condition:
Thyroid cancer
Stage/Subtype:
anaplastic thyroid cancer
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
OXC4T4-302
, NCT00507429
2.
A Phase 1/2 Dose Finding Study of an Experimental New Drug CS7017, an Oral PPAR? Agonist Taken by Mouth Twice Daily in Combination With Paclitaxel Chemotherapy
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
CS7017-A-U103
, NCT00603941
3.
Phase II Study of Sorafenib in Patients With Advanced Anaplastic Thyroid Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CASE-5304
, CASE 5304, 7037, NCI-7037, NCT00126568
4.
Phase II Study of Sorafenib Tosylate in Patients With Metastatic or Unresectable, Iodine Non-Avid, Resistant Thyroid Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
UPCC-03305
, UPCC#03305, UPCC-802861, NCT00601783
5.
Phase II Study of Pazopanib Hydrochloride in Patients With Advanced Thyroid Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
MAYO-MC057H
, MC057H, 7627, NCT00625846
6.
RAD001 for Patients With Radioiodine Refractory Thyroid Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
09-049
, NCT00936858
7.
Study of Iodine I 131 Therapy in Patients With Thyroid Cancer
Phase:
No phase specified
Type:
Diagnostic, Treatment
Status:
Active
Age:
18 to 100
Sponsor:
NCI
Protocol IDs:
JHOC-J0628
, NCT00416949
8.
A Pilot Clinical Trial for Poorly Differentiated Thyroid Cancer - Correlation to Retinoind and Peroxisome-Proliferator-Activated Receptor (PPARy) Expression
Phase:
No phase specified
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
COMIRB# 07-0727
, NCT00718770
Select All on Page
Help with Results
NCI Home
|
Text-Only Version
|
Contact Us
|
Policies
|
Accessibility
|
RSS
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute
